News

The safer aspirin PA 325 is a patented formulation of 325mg of aspirin surrounded by a 20mg coating of an immediate release formulation of a proton pump inhibitor.

However, the company intends to allow patients currently in the screening process to enroll in the phase III clinical trials if they qualify, going beyond the 200 patient

Solvay alleged that KV Pharmaceuticals' subsidiary Ethex's promotion of its Pangestyme CN 10 and Pangestyme CN 20 pancreatic enzyme products and references to Solvay's Creon 10 and Creon

Once the FDA approves a drug for any indicated use, physicians may legally prescribe the drug for different conditions and for patients in other age groups. Over the

In October 2006, Teva settled a patent dispute with the Purdue Frederick Company and certain of its affiliates pertaining to Teva's generic version of Purdue's OxyContin tablets. The

They discovered that the pain killer was most effective for children with broken bones, bruises and sprains. Ibuprofen beat generic acetaminophen and codeine in a study of 300

“We are excited to complete what we believe is the first license and co-development deal of such an innovative investigational pharmaceutical from a China-based company. Huya's mission is

A total of 147 subjects with chronic plaque psoriasis have been enrolled and are undergoing a 12-week course of treatment with one of three different concentrations of CTA018

Initial analyses of the study results show that it met its primary objective to show that faropenem was effective in eradicating pathogens from the middle ear and to